Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 216

Similar articles for PubMed (Select 23578110)

1.

Intra-osseous injection of donor mesenchymal stem cell (MSC) into the bone marrow in living donor kidney transplantation; a pilot study.

Lee H, Park JB, Lee S, Baek S, Kim H, Kim SJ.

J Transl Med. 2013 Apr 11;11:96. doi: 10.1186/1479-5876-11-96.

2.

Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.

Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ.

Stem Cells Transl Med. 2013 Feb;2(2):107-11. doi: 10.5966/sctm.2012-0114. Epub 2013 Jan 24.

3.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

Garcia-Morales R, Carreno M, Mathew J, Cirocco R, Zucker K, Ciancio G, Burke G, Roth D, Temple D, Fuller L, Esquenazi V, Eskind L, Kenyon NS, Ricordi C, Tzakis A, Miller J.

Transplantation. 1998 Apr 15;65(7):956-65.

PMID:
9565101
4.

Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.

Trivedi HL, Vanikar AV, Modi PR, Shah VR, Vakil JM, Trivedi VB, Khemchandani SI.

Transplant Proc. 2005 Mar;37(2):737-42.

PMID:
15848518
5.

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

Garcia-Morales R, Carreno M, Mathew J, Zucker K, Cirocco R, Ciancio G, Burke G, Roth D, Temple D, Rosen A, Fuller L, Esquenazi V, Karatzas T, Ricordi C, Tzakis A, Miller J.

J Clin Invest. 1997 Mar 1;99(5):1118-29. Erratum in: J Clin Invest 1997 May;99(9):2295.

6.

Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.

Ciancio G, Burke GW, Garcia-Morales R, Suzart K, Rosen A, Ricordi C, Kenyon NS, Mathew JM, Tzakis AG, Esquenazi V, Miller J.

Transplantation. 2002 Aug 27;74(4):488-96.

PMID:
12352907
7.

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

Perico N, Casiraghi F, Introna M, Gotti E, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Marasà M, Golay J, Noris M, Remuzzi G.

Clin J Am Soc Nephrol. 2011 Feb;6(2):412-22. doi: 10.2215/CJN.04950610. Epub 2010 Oct 7.

8.

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

Perico N, Casiraghi F, Gotti E, Introna M, Todeschini M, Cavinato RA, Capelli C, Rambaldi A, Cassis P, Rizzo P, Cortinovis M, Noris M, Remuzzi G.

Transpl Int. 2013 Sep;26(9):867-78. doi: 10.1111/tri.12132. Epub 2013 Jun 6.

PMID:
23738760
9.

Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study.

Peng Y, Ke M, Xu L, Liu L, Chen X, Xia W, Li X, Chen Z, Ma J, Liao D, Li G, Fang J, Pan G, Xiang AP.

Transplantation. 2013 Jan 15;95(1):161-8. doi: 10.1097/TP.0b013e3182754c53. Erratum in: Transplantation. 2014 Mar 27;97(6):e37. Pan, Guanghui [added].

PMID:
23263506
10.

Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.

Pan H, Zhao K, Wang L, Zheng Y, Zhang G, Mai H, Han Y, Yang L, Guo S.

J Surg Res. 2010 May 15;160(2):315-24. doi: 10.1016/j.jss.2008.09.027. Epub 2008 Nov 4.

PMID:
19524257
11.

Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.

Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, Burke GW, Carreno M, Temple D, Tzakis AG, Ricordi C, Miller J, Esquenazi V.

Transplantation. 2000 Dec 27;70(12):1675-82.

PMID:
11152096
12.

Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.

Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C.

JAMA. 2012 Mar 21;307(11):1169-77. doi: 10.1001/jama.2012.316.

PMID:
22436957
13.

Six-year clinical effect of donor bone marrow infusions in renal transplant patients.

Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GW 3rd, Roth D, Kupin W, Tzakis AG, Ricordi C, Rosen A, Fuller L, Esquenazi V.

Transplantation. 2001 Apr 15;71(7):827-35.

PMID:
11349712
14.

Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.

Kim YH, Wee YM, Choi MY, Lim DG, Kim SC, Han DJ.

Mol Med. 2011;17(7-8):697-708. doi: 10.2119/molmed.2010.00098. Epub 2011 Feb 25.

15.

Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients.

Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Alwayn IP, Weimar W, Hoogduijn MJ.

Transplantation. 2009 Mar 27;87(6):896-906. doi: 10.1097/TP.0b013e31819b3d72.

PMID:
19300194
16.

Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.

Wang Y, Liu J, Xu C, Zhang W, Bai L, Li N, Liu Y, Wang Y, Su Y, Hu D.

J Surg Res. 2011 Nov;171(1):e123-31. doi: 10.1016/j.jss.2011.06.020. Epub 2011 Jul 13.

PMID:
21920556
17.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.

Mathew JM, Garcia-Morales RO, Carreno M, Jin Y, Fuller L, Blomberg B, Cirocco R, Burke GW, Ciancio G, Ricordi C, Esquenazi V, Tzakis AG, Miller J.

Transpl Immunol. 2003 Jul-Sep;11(3-4):307-21. Review.

PMID:
12967784
18.

[Effects of donor-specific bone marrow cell infusion on chimerism and acute rejection in kidney transplantation].

Fu YW, Wang WG, Zhou HL, Zhang WL, Yang SJ, Wang JG.

Zhonghua Yi Xue Za Zhi. 2004 Dec 2;84(23):1983-5. Chinese.

PMID:
15730811
19.

[Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].

Huang K, Zhou DH, Huang SL, Liang SH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):1049-53. Chinese.

PMID:
16403278
20.

Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells.

Siegel G, Kluba T, Hermanutz-Klein U, Bieback K, Northoff H, Schäfer R.

BMC Med. 2013 Jun 11;11:146. doi: 10.1186/1741-7015-11-146.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk